Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Retained Earnings (2017 - 2025)

Anaptysbio's Retained Earnings history spans 9 years, with the latest figure at -$772.6 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 1.74% year-over-year to -$772.6 million; the TTM value through Dec 2025 reached -$772.6 million, down 1.74%, while the annual FY2025 figure was -$772.6 million, 1.74% down from the prior year.
  • Retained Earnings reached -$772.6 million in Q4 2025 per ANAB's latest filing, up from -$822.2 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $161000.0 in Q1 2025 to a low of -$837.3 million in Q2 2025.
  • Average Retained Earnings over 5 years is -$323.3 million, with a median of -$182.0 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: tumbled 322429.73% in 2022, then soared 125.8% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$422000.0 in 2021, then tumbled by 1143.13% to -$5.2 million in 2022, then skyrocketed by 84.81% to -$797000.0 in 2023, then tumbled by 95173.15% to -$759.3 million in 2024, then decreased by 1.74% to -$772.6 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Retained Earnings are -$772.6 million (Q4 2025), -$822.2 million (Q3 2025), and -$837.3 million (Q2 2025).